March 25 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST LICENSEE FILES FOR MARKETING APPROVAL TO TREAT EPIDERMOLYSIS BULLOSA
March 25 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST LICENSEE FILES FOR MARKETING APPROVAL TO TREAT EPIDERMOLYSIS BULLOSA